HUMALOG 100 jedinica/1 mL otopina za injekciju u ulošku Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

humalog 100 jedinica/1 ml otopina za injekciju u ulošku

eli lilly bh d.o.o. - inzulin lispro - otopina za injekciju u ulošku - 100 jedinica/1 ml - 1 ml otopine za injekciju u ulošku sadrži: 100 jedinica (odgovara 3,5 mg insulina lispro)

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Vixargio 2,5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vixargio 2,5 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - rivaroksaban - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 2,5 mg rivaroksabana

Rivaroksaban APC 2,5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

rivaroksaban apc 2,5 mg filmom obložene tablete

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - rivaroksaban - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 2,5 mg rivaroksabana

Rufixalo 2,5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

rufixalo 2,5 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - rivaroksaban - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 2,5 mg rivaroksabana

Amzelix 10 mg/10 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

amzelix 10 mg/10 mg filmom obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - donepezilklorid hidrat memantinklorid - filmom obložena tableta - urbroj: jedna tableta sadrži 10 mg donepezilklorida u obliku donepezilklorid hidrata (što odogvara 9,14 mg donepezila) i 10 mg memantinklorida (što odgovara 8,31 mg memantina)